These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy. Hedner U Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514 [No Abstract] [Full Text] [Related]
5. Characterization and significance of urinary fibrin degradation products. Cortes P; Potter EV; Kwaan HC J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524 [No Abstract] [Full Text] [Related]
6. [Fibrinuria in human renal transplantation]. Antoine B; Neveu T; Dorrington Ward P Rev Fr Etud Clin Biol; 1969 Oct; 14(8):744-53. PubMed ID: 4904573 [No Abstract] [Full Text] [Related]
7. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products. Ekert H; Muntz RH Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329 [No Abstract] [Full Text] [Related]
8. Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease. Marchesi SL; Aptekar RG; Steinberg AD; Gralnick HR; Decker JL Arthritis Rheum; 1974; 17(2):158-64. PubMed ID: 4592571 [No Abstract] [Full Text] [Related]
9. Rapid latex-screening test for urine F.D.P. Cash JD; Hoq MS; Cunningham M; Anderton JL Lancet; 1973 Jan; 1(7795):153-4. PubMed ID: 4118498 [No Abstract] [Full Text] [Related]
10. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis. Ekberg M; Pandolfi M Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine]. Bendel M; Oetliker O; Montandon A; Beck EA Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647 [TBL] [Abstract][Full Text] [Related]
12. Urokinase-induced fibrinolysis of 125-I-fibrin. Conditions for first-order activation kinetics, density-gradient separation of split products, and a microassay. Ball AP; Day ED Thromb Diath Haemorrh; 1970 Dec; 24(3):463-74. PubMed ID: 5503943 [No Abstract] [Full Text] [Related]
13. FIBRINOGEN BREAKDOWN PRODUCTS. LEWIS JH; WILSON JH Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449 [No Abstract] [Full Text] [Related]
14. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies. Marder VJ; Matchett MO; Sherry S Am J Med; 1971 Jul; 51(1):71-82. PubMed ID: 4998883 [No Abstract] [Full Text] [Related]
18. Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man. Collen D; Semeraro N; Tricot JP; Vermylen J J Appl Physiol Respir Environ Exerc Physiol; 1977 Jun; 42(6):865-73. PubMed ID: 142076 [TBL] [Abstract][Full Text] [Related]
19. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma. Norén I; Ramström G; Wallén P Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332 [TBL] [Abstract][Full Text] [Related]
20. Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. Clarkson AR; MacDonald MK; Cash JD; Robson JS Br Med J; 1972 Jul; 3(5821):255-60. PubMed ID: 5046478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]